Evidence of two distinct functionally specialized fibroblast lineages in breast stroma

BACKGROUND: The terminal duct lobular unit (TDLU) is the most dynamic structure in the human breast and the putative site of origin of human breast cancer. Although stromal cells contribute to a specialized microenvironment in many organs, this component remains largely understudied in the human breast. We here demonstrate the impact on epithelium of two lineages of breast stromal fibroblasts, one of which accumulates in the TDLU while the other resides outside the TDLU in the interlobular stroma. METHODS: The two lineages are prospectively isolated by fluorescence activated cell sorting (FACS) based on different expression levels of CD105 and CD26. The characteristics of the two fibroblast lineages are assessed by immunocytochemical staining and gene expression analysis. The differentiation capacity of the two fibroblast populations is determined by exposure to specific differentiating conditions followed by analysis of adipogenic and osteogenic differentiation. To test whether the two fibroblast lineages are functionally imprinted by their site of origin, single cell sorted CD271(low)/MUC1(high) normal breast luminal epithelial cells are plated on fibroblast feeders for the observation of morphological development. Epithelial structure formation and polarization is shown by immunofluorescence and digitalized quantification of immunoperoxidase-stained cultures. RESULTS: Lobular fibroblasts are CD105(high)/CD26(low) while interlobular fibroblasts are CD105(low)/CD26(high). Once isolated the two lineages remain phenotypically stable and functionally distinct in culture. Lobular fibroblasts have properties in common with bone marrow derived mesenchymal stem cells and they specifically convey growth and branching morphogenesis of epithelial progenitors. CONCLUSIONS: Two distinct functionally specialized fibroblast lineages exist in the normal human breast, of which the lobular fibroblasts have properties in common with mesenchymal stem cells and support epithelial growth and morphogenesis. We propose that lobular fibroblasts constitute a specialized microenvironment for human breast luminal epithelial progenitors, i.e. the putative precursors of breast cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-016-0769-2) contains supplementary material, which is available to authorized users

A CD146 FACS Protocol Enriches for Luminal Keratin 14/19 Double Positive Human Breast Progenitors

Publisher's version (útgefin grein).Human breast cancer is believed to arise in luminal progenitors within the normal breast. A subset of these are double positive (DP) for basal and luminal keratins and localizes to a putative stem cell zone within ducts. We here present a new protocol based on a combination of CD146 with CD117 and CD326 which provides an up to thirty fold enrichment of the DP cells. We show by expression profiling, colony formation, and morphogenesis that CD146high/CD117high/CD326high DP cells belong to a luminal progenitor compartment. While these DP cells are located quite uniformly in ducts, with age a variant type of DP (vDP) cells, which is mainly CD146-negative, accumulates in lobules. Intriguingly, in specimens with BRCA1 mutations known to predispose for cancer, higher frequencies of lobular vDP cells are observed. We propose that vDP cells are strong candidates for tracing the cellular origin of breast cancer.We thank Lena Kristensen, Tove Marianne Lund and Anita Sharma Friismose for expert technical assistance. Benedikte Thuesen and Trine Foged Henriksen, Capio CFR Hospitaler are acknowledged for providing breast biopsy material. The Core Facility for Integrated Microscopy (University of Copenhagen) is acknowledged for confocal microscope accessibility. This work was supported by Novo Nordisk Fonden and Danish Research Council grant 10-092798 (to DanStem), Toyota-Fonden Denmark and Anita og Tage Therkelsens Fond (to R.V.), Familien Erichsens Mindefond and Vera og Carl Johan Michaelsens Legat (to J.K.), Harboefonden, Else og Mogens Wedell-wedellborgs Fond and Danish Cancer Society Grant R146-A9257 (to L.R.-J.).Peer Reviewe

Measurement of the Rheology of Crude Oil in Equilibrium with CO2 at Reservoir Conditions.

A rheometer system to measure the rheology of crude oil in equilibrium with carbon dioxide (CO2) at high temperatures and pressures is described. The system comprises a high-pressure rheometer which is connected to a circulation loop. The rheometer has a rotational flow-through measurement cell with two alternative geometries: coaxial cylinder and double gap. The circulation loop contains a mixer, to bring the crude oil sample into equilibrium with CO2, and a gear pump that transports the mixture from the mixer to the rheometer and recycles it back to the mixer. The CO2 and crude oil are brought to equilibrium by stirring and circulation and the rheology of the saturated mixture is measured by the rheometer. The system is used to measure the rheological properties of Zuata crude oil (and its toluene dilution) in equilibrium with CO2 at elevated pressures up to 220 bar and a temperature of 50 °C. The results show that CO2 addition changes the oil rheology significantly, initially reducing the viscosity as the CO2 pressure is increased and then increasing the viscosity above a threshold pressure. The non-Newtonian response of the crude is also seen to change with the addition of CO2

Additional file 1: Figure S1. of Evidence of two distinct functionally specialized fibroblast lineages in breast stroma

Confirmation of microarray analysis by RT-qPCR. RT-qPCR of a representative subset of differentially expressed genes between CD105high and CD26high fibroblasts presented as the relative normalized expression level in CD105high to CD26high fibroblasts. The genes analyzed include signal peptide, CUB domain and EGF like domain containing 3 (SCUBE3), CD105/endoglin (ENG), growth differentiation factor 6 (GDF6), collagen type XI alpha 1 chain (COL11A1), tetraspanin 2 (TSPAN2), collagen type IV alpha 1 chain (COL4A1), actin, alpha 2, smooth muscle, aorta (ACTA2), tenascin C (TNC), activin A receptor like type 1 (ACVRL1), collagen type XV alpha 1 chain (COL15A1), calponin 1 (CNN1), dermatopontin (DPT), fibronectin type III domain containing 1 (FNDC1), activin A receptor type 2A (ACVR2A), laminin subunit alpha 2 (LAMA2), interleukin 1 receptor like 1 (IL1RL1), interleukin 33 (IL33), hepatocyte growth factor (HGF), complement factor B (CFB); G protein-coupled receptor class C group 5 member B (GPRC5B), complement component 3 (C3) and decorin (DCN). Error bars represent mean +/− SD. (PDF 34 kb